Conform Trial: Major Milestone Achieved

We are thrilled to celebrate a major milestone in clinical research! On August 8, 2025, our team successfully completed the very first implant day for the Conform Clinical Trial, enrolling and treating our first three patients with the Conformal CLAAS System for Left Atrial Appendage Occlusion.

This remarkable achievement was made possible through the dedication, collaboration, and unwavering commitment of Dr. Giancarlo Speziani, Anne Dallas, Cynthia Paysor, and Gerardo Bustos. Their expertise and teamwork has set the stage for continued excellence in advancing cardiovascular innovation.

The Conform Trial is designed to evaluate the safety and effectiveness of the Conformal CLAAS System, an important step toward expanding treatment options for patients with atrial fibrillation.

Congratulations to the entire team on this inspiring accomplishment!

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News

Alcohol, Marijuana and Type 1 Diabetes:

Whether it's a backyard barbecue, a football game or dinner with friends, alcohol and marijuana are common parts of social life. For people with Type 1 diabetes (T1D), understanding how they affect...

News

The Science That Moves Medicine Forward:

Have you ever wondered how breakthrough medicines are developed, how doctors determine the most effective treatments, or how healthcare continues to advance? The answer lies in clinical research—the...

News

Advancing Cancer Research Closer to Home

At AdventHealth, we believe research is not separate from care. We believe the advancements made are what allow us to help our patients feel whole. That commitment is reflected in a new collaboration...

News

Moving More, Managing Better

For people living with type 1 diabetes, managing blood sugar is rarely simple. It’s a daily balancing act involving insulin, food, physical activity, technology and a constant stream of decisions.